Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-γ production

Human Immunology

Volumn 70, Issue 6, 2009, Pages 383-390

  Castellano, Lúcio Roberto ^a   Filho, Dalmo Correia ^a   Argiro, Laurent ^b   Dessein, Helia ^b   Prata, Aluízio ^a   Dessein, Alain ^b   Rodrigues, Virmondes ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b INSERM   (France)

Author keywords

Antibodies; Cutaneous leishmaniasis; Cytokines; IFN gamma; IL 10

Indexed keywords

ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY BLOOD LEVEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN LEISHMANIASIS; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELLS, CULTURED; CYTOKINES; HUMANS; IMMUNOGLOBULIN ISOTYPES; INTERFERON-GAMMA; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; TH1 CELLS; TH2 CELLS;

EID: 67349194081     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.01.007     Document Type: Article

References (31)

1. Convit J., Ulrich M., Fernandez C.T., Tapia F.J., Caceres-Dittmar G., Castes M., et al. The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 87 (1993) 444-448
2. Sacks D., and Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2 (2002) 845-858
3. Carvalho E.M., Correia Filho D., Bacellar O., Almeida R.P., Lessa H., and Rocha H. Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis. Am J Trop Med Hyg 53 (1995) 273-277
4. Trujillo C.M., Robledo S.M., Franco J.L., Velez I.D., Erb K.J., and Patino P.J. Endemically exposed asymptomatic individuals show no increase in the specific Leishmania (Viannia) panamensis-Th1 immune response in comparison to patients with localized cutaneous leishmaniasis. Parasite Immunol 24 (2002) 455-462
5. Bourreau E., Prevot G., Gardon J., Pradinaud R., and Launois P. High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment. J Infect Dis 184 (2001) 1628-1630
6. Caceres-Dittmar G., Tapia F.J., Sanchez M.A., Yamamura M., Uyemura K., Modlin R.L., et al. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol 91 (1993) 500-505
7. Louzir H., Melby P.C., Ben Salah A., Marrakchi H., Aoun K., Ben Ismail R., et al. Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major. J Infect Dis 177 (1998) 1687-1695
8. Pirmez C., Yamamura M., Uyemura K., Paes-Oliveira M., Conceicao-Silva F., and Modlin R.L. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 91 (1993) 1390-1395
9. Salhi A., Rodrigues Jr. V., Santoro F., Dessein H., Romano A., Castellano L.R., et al. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis. J Immunol 180 (2008) 6139-6148
10. Junqueira Pedras M., Orsini M., Castro M., Passos V.M., and Rabello A. Antibody subclass profile against Leishmania braziliensis and Leishmania amazonensis in the diagnosis and follow-up of mucosal leishmaniasis. Diagn Microbiol Infect Dis 47 (2003) 477-485
11. Romero G.A., de la Gloria Orge Orge M., de Farias Guerra M.V., Paes M.G., de Oliveira Macedo V., and de Carvalho E.M. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil. Acta Trop 93 (2005) 49-56
12. Rodriguez V., Centeno M., and Ulrich M. The IgG isotypes of specific antibodies in patients with American cutaneous leishmaniasis; relationship to the cell-mediated immune response. Parasite Immunol 18 (1996) 341-345
13. Melby P.C., Andrade-Narvaez F.J., Darnell B.J., Valencia-Pacheco G., Tryon V.V., and Palomo-Cetina A. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infect Immun 62 (1994) 837-842
14. Rodrigues Jr. V., Santana da Silva J., and Campos-Neto A. Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis. Infect Immun 66 (1998) 1233-1236
15. Anderson C.F., Mendez S., and Sacks D.L. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice. J Immunol 174 (2005) 2934-2941
16. Chatelain R., Mauze S., Varkila K., and Coffman R.L. Leishmania major infection in interleukin-4 and interferon-gamma depleted mice. Parasite Immunol 21 (1999) 423-431
17. de Souza-Neto S.M., Carneiro C.M., Vieira L.Q., and Afonso L.C. Leishmania braziliensis: Partial control of experimental infection by interleukin-12 p40 deficient mice. Mem Inst Oswaldo Cruz 99 (2004) 289-294
18. Ajdary S., Alimohammadian M.H., Eslami M.B., Kemp K., and Kharazmi A. Comparison of the immune profile of nonhealing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection. Infect Immun 68 (2000) 1760-1764
19. Stenger S., Thuring H., Rollinghoff M., and Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med 180 (1994) 783-793
20. Diaz N.L., Fernandez M., Figueira E., Ramirez R., Monsalve I.B., and Tapia F.J. Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis. Clin Exp Dermatol 28 (2003) 288-293
21. Qadoumi M., Becker I., Donhauser N., Rollinghoff M., and Bogdan C. Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous leishmaniasis. Infect Immun 70 (2002) 4638-4642
22. Cabrera M., Shaw M.A., Sharples C., Williams H., Castes M., Convit J., et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 182 (1995) 1259-1264
23. Da-Cruz A.M., de Oliveira M.P., De Luca P.M., Mendonca S.C., and Coutinho S.G. Tumor necrosis factor-alpha in human American tegumentary leishmaniasis. Mem Inst Oswaldo Cruz 91 (1996) 225-229
24. Heinzel F.P., Sadick M.D., Mutha S.S., and Locksley R.M. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci U S A 88 (1991) 7011-7015
25. Sadick M.D., Heinzel F.P., Holaday B.J., Pu R.T., Dawkins R.S., and Locksley R.M. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 171 (1990) 115-127
26. Coutinho S.G., Da-Cruz A.M., Bertho A.L., Santiago M.A., and De-Luca P. Immunologic patterns associated with cure in human American cutaneous leishmaniasis. Braz J Med Biol Res 31 (1998) 139-142
27. Chatelain R., Mauze S., and Coffman R.L. Experimental Leishmania major infection in mice: Role of IL-10. Parasite Immunol 21 (1999) 211-218
28. Padigel U.M., Alexander J., and Farrell J.P. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J Immunol 171 (2003) 3705-3710
29. Belkaid Y., Piccirillo C.A., Mendez S., Shevach E.M., and Sacks D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420 (2002) 502-507
30. Rocha P.N., Almeida R.P., Bacellar O., de Jesus A.R., Filho D.C., and Filho A.C. Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis. J Infect Dis 180 (1999) 1731-1734
31. Campanelli A.P., Roselino A.M., Cavassani K.A., Pereira M.S., Mortara R.A., Brodskyn C.I., et al. CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis 193 (2006) 1313-1322